Percutaneous Transvascular Implantation of a Coronary Sinus Reducing Stent

Stanak M, Rothschedl E
Record ID 32018000625
English
Authors' objectives: The coronary sinus reducing stent (CSRS) is a stainless-steel mesh that is designed to create a focal narrowing in the lumen of the coronary sinus. The CSRS is pre-mounted on a customised hourglass shaped balloon catheter inserted into its place via the jugular vein under local anaesthesia. The aim of this systematic review was to investigate the use of CSRS in refractory angina pectoris patients when compared to sham CSRS procedure.
Authors' results and conclusions: For the assessment of clinical effectiveness, one randomised controlled trial met the inclusion criteria. For the assessment of safety, seven studies met the inclusion criteria. The overall strength of evidence for effectiveness and safety was moderate.
Authors' recommendations: The inclusion in the Austrian catalogue of benefits is currently not recommended. Even though the current evidence indicates that the assessed technology CSRS is potentially more effective than sham intervention for refractory angina pectoris patients (in terms of Canadian Cardiovascular Society and Seattle Angina Questionnaire scores) who have no other alternative interventions available, the lacking internal validity of the studies undermines the partially positive results. A re-evaluation is recommended in 2022.
Details
Project Status: Completed
URL for project: https://aihta.at/page/bewertung-medizinischer-einzelleistungen-mel-2019-1/en
Year Published: 2020
URL for published report: http://eprints.aihta.at/1256/1/DSD_121.pdf
URL for additional information: http://eprints.aihta.at/1256/
English language abstract: An English language summary is available
Publication Type: Full HTA
Country: Austria
MeSH Terms
  • Angina Pectoris
  • Coronary Sinus
  • Percutaneous Coronary Intervention
Keywords
  • Coronary sinus reducing stent
  • CSRS
  • refractory angina pectoris
  • ischemic heart disease
  • percutaneous transvascular implantation
Contact
Organisation Name: Ludwig Boltzmann Institute for Health Technology Assessment
Contact Address: Ludwig Boltzmann Institute for fuer Health Technology Assessment (LBI-HTA), Garnisongasse 7/rechte Stiege Mezzanin (Top 20), 1090 Vienna, Austria. Tel: +43 1 236 8119 - 0 Fax: +43 1 236 8119 - 99
Contact Name: tarquin.mittermayr@aihta.at
Contact Email: office@aihta.at
Copyright: Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.